Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PEARL Intervention to Reduce Depression Among Adults With Epilepsy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by University of Washington.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00459329
First received: April 9, 2007
Last updated: June 2, 2008
Last verified: June 2008
  Purpose

The purpose of this study is to test the effectiveness of a home-based depression treatment intervention called "Program to Encourage Active, Rewarding Lives (PEARL)". We hypothesize that over a 12-month period, compared to usual care, those receiving the PEARL intervention will show more improvement with their depression, have higher quality of life and function, and use fewer medical services.


Condition Intervention
Depression
Epilepsy
Behavioral: Program to Encourage Active, Rewarding Lives (PEARL)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: PEARL Intervention to Reduce Depression Among Adults With Epilepsy

Resource links provided by NLM:


Further study details as provided by University of Washington:

Primary Outcome Measures:
  • Mean SCL-20 depression scores [ Time Frame: 6 & 12 months post-baseline ] [ Designated as safety issue: No ]
  • Depression treatment response, defined as greater than 50% decrease in SCL-20 score from baseline [ Time Frame: 6 & 12 months post-baseline ] [ Designated as safety issue: No ]
  • Complete depression remission defined as SCL-20 score less than 0.5. [ Time Frame: 6 & 12 months post-baseline ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Quality of Life [ Time Frame: 6 & 12 months post-baseline ] [ Designated as safety issue: No ]
  • Pharmaceutical and health care utilization and costs [ Time Frame: 6 & 12 months post-baseline ] [ Designated as safety issue: No ]
  • Seizure frequency and severity [ Time Frame: 6 & 12 months post-baseline ] [ Designated as safety issue: No ]
  • Satisfaction with epilepsy health care [ Time Frame: 6 & 12 months post-baseline ] [ Designated as safety issue: No ]
  • Epilepsy Self-Efficacy [ Time Frame: 6 & 12 months post-baseline ] [ Designated as safety issue: No ]

Enrollment: 80
Study Start Date: March 2007
Estimated Study Completion Date: March 2009
Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Program to Encourage Active, Rewarding Lives (PEARL)

    Eight 50-minute in-home sessions over 19 weeks with a masters-level social work counselor using Problem Solving Therapy (PST).

    PST is a skills-enhancing behavioral depression treatment based on the assumption that an accumulation of problems in living cause and maintain depressive symptoms, and through systematically identifying and addressing these problems, patients achieve decreased depressive symptoms. Counselors also help participants to increase social and physical activities and to incorporate pleasant activities into patients' lives.

    Counselors provide education and monitoring for antidepressant use, and work with the participant's physician and PEARL psychiatrist to recommend initiating or adjusting antidepressant medications. The PHQ-9 is administered at each session to track depression change.

    After 19 weeks, counselors will maintain monthly telephone calls with participants, administering the PHQ-9 and assessing PST success.

Detailed Description:

Compared to non-depressed individuals with epilepsy, those with depression have significantly higher rates of suicide, lower social and occupational functioning, decreased quality of life independent of seizure frequency, and higher non-psychiatric health care utilization. Adults with epilepsy are more likely to be homebound as a result of reduced function and restrictions in driving, opportunities to obtain enhanced quality of care for depression may be limited. This study tests the effectiveness of a home-based multi-modal depression treatment intervention called Program to Encourage Active, Rewarding Lives (PEARL). PEARL consists of problem solving treatment, social and physical activation, pleasant events scheduling, support and education regarding antidepressant medication use as well as psychiatric consultation and recommendations regarding initiation or adjustment of antidepressant medications.

In a sample of adults with epilepsy who have minor depression, major depression and/or dysthymia, we hypothesize that over a 12-month period, compared to usual care, those randomized to the PEARL intervention will: achieve higher levels of depression response and remission, achieve higher quality of life and function, and utilize less non-psychiatric health care.

By providing a multi-modal, home-based stepped collaborative care intervention for adults with depression and epilepsy, this program will offer practical alternatives to usual care and will provide a program for improving depression outcomes, quality of life and potentially, epilepsy outcomes.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Home address within 30 miles of Seattle
  • Diagnosis of epilepsy (ICD-9 code 345.XX)
  • Appointment in the UW REC or Neurology clinic in the past 2 years and currently enrolled in this clinic.
  • Current age older than 18 years
  • Diagnosis of major depression, minor depression or dysthymia
  • Ability to speak/read English

Exclusion Criteria:

  • Alcohol and/or substance abuse/dependence based on a score greater than 1 on 4-item validated CAGE-AID
  • Cognitive impairment based on a score less than 3 on a 6-item validated cognitive screen
  • Diagnosis of bipolar disorder, schizophrenia/schizoaffective disorder or other psychotic disorder
  • Women who are pregnant or nursing
  • Terminal medical illness
  • Those currently seeing or planning to see a psychiatrist
  • Those with suicidal ideation nearly every day
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00459329

Locations
United States, Washington
Regional Epilepsy Center, Harborview Medical Center
Seattle, Washington, United States, 98104
Sponsors and Collaborators
University of Washington
Investigators
Principal Investigator: Paul S Ciechanowski, MD, MPH University of Washington
  More Information

No publications provided by University of Washington

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Paul Ciechanowski, MD, MPH, University of Washington
ClinicalTrials.gov Identifier: NCT00459329     History of Changes
Other Study ID Numbers: 06-4237-C 01, SIP 07-2006
Study First Received: April 9, 2007
Last Updated: June 2, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by University of Washington:
Depression
Epilepsy
Problem-Solving Therapy
Mental Health
Neurology
Home-based health care
Community-based program
Collaborative care

Additional relevant MeSH terms:
Depression
Depressive Disorder
Epilepsy
Behavioral Symptoms
Brain Diseases
Central Nervous System Diseases
Mental Disorders
Mood Disorders
Nervous System Diseases

ClinicalTrials.gov processed this record on November 25, 2014